Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

278.26
+5.261.93%
Post-market: 278.260.00000.00%19:30 EDT
Volume:767.56K
Turnover:213.40M
Market Cap:13.28B
PE:-57.00
High:280.40
Open:276.01
Low:275.63
Close:273.00
52wk High:303.31
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:1.05
T/O Rate:1.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.68
PE(LYR):-95.55

Loading ...

Charles River Q1 FY26 turns to net loss of $14.8 million; revenue rises 1.2% to $995.8 million

Reuters
·
May 07

Charles River Q1 Adj. EPS $2.06 Beats $1.94 Estimate, Sales $995.830M Beat $977.486M Estimate

Benzinga Earnings
·
May 07

Charles River Laboratories International Inc - Reaffirms 2026 Guidance for Organic Revenue and Non-Gaap Earnings per Share

THOMSON REUTERS
·
May 07

Charles River Outlook FY Revenue Growth -5.5 to -4%

THOMSON REUTERS
·
May 07

Charles River Laboratories International - Expects to Complete Sale of Certain European Discovery Services Sites in May 2026

THOMSON REUTERS
·
May 07

Press Release: Pharming Group reports first quarter 2026 financial results; on track for Joenja(R) U.S. pediatric label expansion and launches in Japan and Europe in 2026

Dow Jones
·
May 07

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
May 07

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 05

Earning Preview: Charles River Laboratories this quarter’s revenue is expected to increase by 3.77%, and institutional views are broadly bullish

Earnings Agent
·
Apr 30

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Apr 30

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 29

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 25

Charles River Laboratories International Inc. Stock Slides 9.2%, Underperforms Peers

Dow Jones
·
Apr 24

AbbVie receives CRL from FDA regarding BLA for trenibotulinumtoxinE

TIPRANKS
·
Apr 24

Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104

GlobeNewswire
·
Apr 24

Revvity Falls 15.5%, Bio-Techne Drops 10.1%, IQVIA Drops 8.3%, Charles River Down 7%

THOMSON REUTERS
·
Apr 23

Shares of Biotech and Medical Equipment Cos Fall After Thermo Fisher Results, Outlook

THOMSON REUTERS
·
Apr 23

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 22

Charles River reports results of restrospective analysis on VCGs in toxicology

TIPRANKS
·
Apr 21

Charles River analysis finds virtual control groups match NOAEL outcomes in toxicology studies

Reuters
·
Apr 21